KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:开放图源暂不可得 入排置信度 0.98

Metronidazole exposure-response and safety in infants.

Rachel L Randell, Stephen J Balevic, Rachel G Greenberg, Michael Cohen-Wolkowiez, Michael J Smith, Daniel K Benjamin, Catherine Bendel, Joseph M Bliss, Hala Chaaban, Rakesh Chhabra, Christiane E L Dammann, L Corbin Downey, Chi D Hornik, Naveed Hussain, Matthew M Laughon, Adrian Lavery, Fernando Moya, Matthew Saxonhouse, Gregory M Sokol, Andrea Trembath, Joern-Hendrik Weitkamp, Christoph P Hornik, Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee

Antimicrob Agents Chemother 69(11) e0037725

PMID40970766
PMCIDPMC12587542
DOI10.1128/aac.00377-25
发表日期2025-09-19
入排依据:未发现恶性肿瘤人群证据。
PubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。
摘要

摘要

The nitroimidazole antibiotic, metronidazole, is frequently prescribed to infants with serious intra-abdominal infections, and multiple dosing recommendations exist. We sought to evaluate the extent to which metronidazole doses and associated exposures achieved desired efficacy and safety in infants enrolled in the Antibiotic Safety in Infants with Complicated Intra-abdominal Infections (SCAMP) trial (NCT01994993). SCAMP participants received intravenous metronidazole as part of multimodal antimicrobial therapy. Participants received a 15 mg/kg loading dose and a 7.5 mg/kg maintenance dose at 24 h. A subsequent 7.5 mg/kg maintenance dose was administered every 12 h for participants of postmenstrual age (PMA) 23 to <34 weeks; 8 h for PMA 34-40 weeks; and 6 h for PMA >40 weeks. We evaluated associations between simulated metronidazole exposures and pre-specified surrogate pharmacodynamic targets and clinical outcomes of efficacy and safety. Nearly 100% of pharmacodynamic targets were met. Infants with therapeutic success (a composite efficacy outcome, defined as the absence of death, negative bacterial blood cultures, and presumptive clinical cure at 30 days) had higher Cmin,ss, Cmax,ss, AUC00-24,ss, and AUCcum compared with infants without therapeutic success. However, the relationships between these exposure measures and therapeutic success were not significant in logistic regression analysis adjusting for gestational age. Despite generally high simulated exposures, no relationships were observed between exposures and prespecified safety events (necrotizing enterocolitis, intestinal strictures, intestinal perforation, positive blood culture, seizures, death, and intraventricular hemorrhage). Findings support metronidazole dosing as administered in term and preterm infants in the SCAMP trial.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。